Carlos Orantes
Chief Executive Officer at Alcanza Clinical Research LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bob Kinard | M | - |
Alcanza Clinical Research LLC
Alcanza Clinical Research LLC Miscellaneous Commercial ServicesCommercial Services Part of hyperCORE International LLP, Alcanza Clinical Research LLC is a clinical research network that operates to develop new therapies. The company is based in Lake Mary, FL. The company was founded in 2021. Carlos E. Orantes has been the CEO of the company since 2022. Alcanza Clinical Research was acquired by hyperCORE International LLP on June 28, 2022. | 1 years |
Matt Maxwell | M | - |
Clinical Research Investments LLC
Clinical Research Investments LLC Miscellaneous Commercial ServicesCommercial Services Clinical Research Holdings LLC provides commercial physical and biological research services. The firm specializes in Phase I/IIa Clinical Pharmacology, Outpatient Studies, In-Hospital Trials, Vaccines, Complex Clinical Trials, Special populations, Phase II, Phase III and Phase IV. The company was founded in 1998 and is headquartered in DeLand, FL.
Alcanza Clinical Research LLC
Alcanza Clinical Research LLC Miscellaneous Commercial ServicesCommercial Services Part of hyperCORE International LLP, Alcanza Clinical Research LLC is a clinical research network that operates to develop new therapies. The company is based in Lake Mary, FL. The company was founded in 2021. Carlos E. Orantes has been the CEO of the company since 2022. Alcanza Clinical Research was acquired by hyperCORE International LLP on June 28, 2022. | - |
Hollis Ryan | F | - |
Alcanza Clinical Research LLC
Alcanza Clinical Research LLC Miscellaneous Commercial ServicesCommercial Services Part of hyperCORE International LLP, Alcanza Clinical Research LLC is a clinical research network that operates to develop new therapies. The company is based in Lake Mary, FL. The company was founded in 2021. Carlos E. Orantes has been the CEO of the company since 2022. Alcanza Clinical Research was acquired by hyperCORE International LLP on June 28, 2022. | 1 years |
Virinder Nohria | M | 70 |
AMPLIFY Clinical, Inc.
AMPLIFY Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL. | - |
Reid K. Petersen | M | - |
AMPLIFY Clinical, Inc.
AMPLIFY Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL. | - |
Thomas Vandervort | M | - |
AMPLIFY Clinical, Inc.
AMPLIFY Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL. | - |
Karri Venn | F | - |
hyperCORE International LLP
hyperCORE International LLP Miscellaneous Commercial ServicesCommercial Services hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn. | - |
Chloe Eckel | F | - |
AMPLIFY Clinical, Inc.
AMPLIFY Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL. | - |
Jeffrey Kingsley | M | - |
hyperCORE International LLP
hyperCORE International LLP Miscellaneous Commercial ServicesCommercial Services hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn. | - |
Michael Casey | M | - |
hyperCORE International LLP
hyperCORE International LLP Miscellaneous Commercial ServicesCommercial Services hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stephen Sullivan | M | 77 |
Accel Clinical Services LLC
Accel Clinical Services LLC BiotechnologyHealth Technology Accel Clinical Services LLC provides clinical research services. It offers clinical trials in a wide range of therapeutic indications to pharmaceuticals, biotech start-ups, and contract research organizations. It conducts Phase I, In-Hospital, vaccine and outpatient Phase II-IV trials. The company was founded in 1998 and is headquartered in DeLand, FL. | 2 years |
Mark Lacy | M | - |
hyperCORE International LLP
hyperCORE International LLP Miscellaneous Commercial ServicesCommercial Services hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn. | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 12 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Carlos Orantes
- Personal Network